Keyphrases
Mast Cells
100%
Histamine
100%
Non-small Cell Lung Cancer Cells
100%
Non-small Cell Lung Cancer (NSCLC)
27%
Lung
18%
Lung Cancer
18%
A549
18%
Lewis Lung Carcinoma
18%
Lewis Lung Carcinoma Cells
18%
Weight Ratio
9%
Sodium
9%
Gene-deficient Mice
9%
Growth in Vitro
9%
Cancer Development
9%
Inflammatory Process
9%
Wild Mice
9%
Targeted Therapy
9%
Tumor Cell Lines
9%
Survival Rate
9%
Chronic Inflammatory Diseases
9%
Negative Regulator
9%
Tumor-promoting
9%
Proliferation Rate
9%
Cell Infiltration
9%
Enhancement Effect
9%
Antihistamines
9%
Reduced Survival
9%
Proliferating Activity
9%
Sash
9%
Nedocromil
9%
Accelerated Growth
9%
Most Common Form
9%
Umbilical Cord Blood
9%
Carcinoma Cell Lines
9%
Mast Cell Stabilizer
9%
Cancer Induction
9%
Cancer Proliferation
9%
ERK Phosphorylation
9%
Lung Tumor Cells
9%
Lung Area
9%
H4 Receptor
9%
Dual Effect
9%
Adenocarcinoma
9%
Sash Mice
9%
Pharmacology, Toxicology and Pharmaceutical Science
Histamine
100%
Lewis Carcinoma
100%
Non Small Cell Lung Cancer
100%
Lung Cancer
50%
Neoplasm
25%
Inflammation
25%
Malignant Neoplasm
25%
Carcinogenesis
25%
Survival Rate
25%
Wild Type Mouse
25%
Antihistaminic Agent
25%
Adenocarcinoma
25%
Nedocromil
25%
Histamine Release Inhibitor
25%
Histamine H4 Receptor
25%
Lung Tumor
25%
Medicine and Dentistry
Cancer Cell
100%
Mast Cell
100%
Histamine
100%
Non Small Cell Lung Cancer
100%
Lung
27%
In Vitro
18%
Lung Cancer
18%
Lewis Lung Carcinoma
18%
Malignant Neoplasm
9%
Neoplasm
9%
Serositis
9%
Targeted Therapy
9%
Survival Rate
9%
Adenocarcinoma
9%
Carcinogenesis
9%
Cord Blood
9%
Nedocromil
9%
Lewis Lung Carcinoma Cell
9%
Lewis Lung Carcinoma Cell Line
9%
Cellular Infiltration
9%
Histamine Antagonist
9%
Lung Tumor Cell Line
9%
Histamine Release Inhibitor
9%
Histamine H4 Receptor
9%
Immunology and Microbiology
Cancer Cell
100%
Mast Cell
100%
Histamine
100%
Wild Type Mouse
9%
Umbilical Cord Blood
9%
Lung Tumor Cell Line
9%
Lewis Lung Carcinoma Cell Line
9%
Lewis Lung Carcinoma Cell
9%
Mast Cell Stabilizer
9%
Nedocromil
9%
Survival Rate
9%